Literature DB >> 11707158

Rapid cycling bipolar disease: new concepts and treatments.

S L Dubovsky1.   

Abstract

Having been recognized by Kraeplin at the beginning of the 20th century, rapid cycling was first described as a specific entity by Dunner et al. in 1974. The prevalence of rapid cycling ranges from 12% to 20% in patients with bipolar disorder who are not selected for a high rate of cycling.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11707158     DOI： 10.1007/s11920-001-0038-6

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN： 1523-3812            Impact factor:   5.285


  148 in total

1.  Mania-like syndrome in a patient with chronic schizophrenia during olanzapine treatment.

Authors:  P Pozo; A G Alcántara
Journal:  J Psychiatry Neurosci       Date:  1998-11       Impact factor: 6.186

2.  Aggression, agitation, and mania with olanzapine.

Authors:  V John; M Rapp; R Pies
Journal:  Can J Psychiatry       Date:  1998-12       Impact factor: 4.356

3.  The use of nimodipine in the treatment of mood disorders.

Authors:  P J Goodnick
Journal:  Bipolar Disord       Date:  2000-09       Impact factor: 6.744

4.  Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group.

Authors:  M Tohen; T G Jacobs; S L Grundy; S L McElroy; M C Banov; P G Janicak; T Sanger; R Risser; F Zhang; V Toma; J Francis; G D Tollefson; A Breier
Journal:  Arch Gen Psychiatry       Date:  2000-09

5.  Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2's neurotrophic effects?

Authors:  G J Moore; J M Bebchuk; K Hasanat; G Chen; N Seraji-Bozorgzad; I B Wilds; M W Faulk; S Koch; D A Glitz; L Jolkovsky; H K Manji
Journal:  Biol Psychiatry       Date:  2000-07-01       Impact factor: 13.382

6.  Comparison of therapeutic modalities for mania.

Authors:  J G Small; M H Klapper; V Milstein; J D Marhenke; I F Small
Journal:  Psychopharmacol Bull       Date:  1996

7.  Rapid cycling bipolar affective disorder. II. Treatment of refractory rapid cycling with high-dose levothyroxine: a preliminary study.

Authors:  M S Bauer; P C Whybrow
Journal:  Arch Gen Psychiatry       Date:  1990-05

8.  Divalproex sodium in the treatment of refractory affective disorders.

Authors:  M R Schaff; J Fawcett; J M Zajecka
Journal:  J Clin Psychiatry       Date:  1993-10       Impact factor: 4.384

Review 9.  Atypical antipsychotics for treatment of depression in schizophrenia and affective disorders. Collaborative Working Group on Clinical Trial Evaluations.

Authors: 
Journal:  J Clin Psychiatry       Date:  1998       Impact factor: 4.384

10.  Is clozapine a mood stabilizer?

Authors:  C A Zarate; M Tohen; M D Banov; M K Weiss; J O Cole
Journal:  J Clin Psychiatry       Date:  1995-03       Impact factor: 4.384
View more
  3 in total

1.  Verapamil augmentation of lithium treatment improves outcome in mania unresponsive to lithium alone: preliminary findings and a discussion of therapeutic mechanisms.

Authors:  Alan G Mallinger; Michael E Thase; Roger Haskett; Joan Buttenfield; David A Luckenbaugh; Ellen Frank; David J Kupfer; Husseini K Manji
Journal:  Bipolar Disord       Date:  2008-12       Impact factor: 6.744

2.  Clinical characteristics and long-term response to mood stabilizers in patients with bipolar disorder and different age at onset.

Authors:  Bernardo Dell'Osso; Massimiliano Buoli; Riccardo Riundi; Nazario D'Urso; Sara Pozzoli; Roberta Bassetti; Emanuela Mundo; A Carlo Altamura
Journal:  Neuropsychiatr Dis Treat       Date:  2009       Impact factor: 2.570

3.  P2RX7: expression responds to sleep deprivation and associates with rapid cycling in bipolar disorder type 1.

Authors:  Lena Backlund; Catharina Lavebratt; Louise Frisén; Pernilla Nikamo; Dzana Hukic Sudic; Lil Träskman-Bendz; Mikael Landén; Gunnar Edman; Marquis P Vawter; Urban Ösby; Martin Schalling
Journal:  PLoS One       Date:  2012-08-28       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.